Auragent Bioscience LLC
Last verified 2026-05-05. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $2.0Mattributed |
|---|---|
| Latest round | grant, $2.0M, 2024-09-01attributed |
| Founded | 2015 |
| Headquarters | Chesterfield, Missouri, USA |
| Industry | bio |
| Stage | unknown |
| Website | auragentbio.com |
Develops infectious-disease therapeutics from microbial natural-product chemistry, with programs in antibacterials and antifungals. Targets pharma partners and biosecurity funders concerned with multi-drug-resistant pathogens. Spun out of academic natural-product chemistry research in St. Louis with a focus on novel scaffolds rather than analog programs.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2024-09-01 | grant | $2.0M | undisclosed |
Detected tech stack
Google Analytics G-?GA4:, Firebase, Next.js
Provenance
| Fact | Status | Basis |
|---|---|---|
| Grant, $2.0M | attributed | sbir named as publisher. No document URL on file. |
| Total raised $2.0M | attributed | sbir named as publisher. No document URL on file. |
| Company existence | self-reported | auragentbio.com, read 2026-05-05 |
| Description | self-reported | auragentbio.com, read 2026-05-05 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.